CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for H.U. Group Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

H.U. Group Holdings Inc
Akasaka Intercity AIR, 1-8-1, Akasaka
Phone: +81 362790801p:+81 362790801 MINATO-KU, TKY  107-0052  Japan Ticker: 45444544
Business Summary
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes--YesYes

Industries
SIC Code Description
8071 Medical laboratories
2835 In vitro and in vivo diagnostic substances
7389 Business services, not elsewhere classified
8011 Offices and clinics of doctors of medicine
7359 Equipment rental and leasing, not elsewhere classified
7352 Medical equipment rental and leasing
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Management Board, President, Group Chief Executive Officer, Representative Executiv ShigekazuTakeuchi 69 6/20/2023 6/1/2016
Chief Financial Officer, Executive Officer AtsukoMurakami 65 6/1/2021 7/1/2020
Chief Technology Officer, Executive Officer, President of Subsidiary KazuyaOmi 44 6/20/2023 6/1/2019
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Fujirebio Europe NV Technologiepark 6 Gent Belgium
Fujirebio Inc. 62-5, Nihonbashi-Hamacho 2-chome Tokyo Japan
SRL, Inc. 2-41-19 Akebono-cho Tachikawa TKY Japan

Business Names
Business Name
4544
Advanced Life Science Institute, Inc.
Baylor Miraca Genetics Laboratories, LLC
19 additional Business Names available in full report.

General Information
Number of Employees: 5,437 (As of 3/31/2023)
Outstanding Shares: 56,819,124 (As of 12/31/2023)
Shareholders: 15,561
Stock Exchange: TYO
Fax Number: +81 359093336


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024